This paper is in the following e-collection/theme issue:

Cyberpharmacies (32) Diabetes (108) Pharmacology and Pharmaceutics (29)

Published on in Vol 24 , No 2 (2022) :February

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25855, first published .
Accessibility of Low-cost Insulin From Illegitimate Internet Pharmacies: Cross-sectional Study

Accessibility of Low-cost Insulin From Illegitimate Internet Pharmacies: Cross-sectional Study

Accessibility of Low-cost Insulin From Illegitimate Internet Pharmacies: Cross-sectional Study

Authors of this article:

Benjamin Penley 1 Author Orcid Image ;   Lana Minshew 2 Author Orcid Image ;   Hui-Han Chen 1 Author Orcid Image ;   Stephen Eckel 1 Author Orcid Image ;   Sachiko Ozawa 1, 3 Author Orcid Image
Article Authors Cited by (4) Tweetations (3) Metrics

Journals

  1. Ozawa S, Billings J, Sun Y, Yu S, Penley B. COVID-19 Treatments Sold Online Without Prescription Requirements in the United States: Cross-sectional Study Evaluating Availability, Safety and Marketing of Medications. Journal of Medical Internet Research 2022;24(2):e27704 View
  2. Shubow S, Sun Q, Nguyen Phan A, Hammell D, Kane M, Lyman G, Gibofsky A, Lichtenstein G, Bloomgarden Z, Cross R, Yim S, Polli J, Wang Y. Prescriber Perspectives on Biosimilar Adoption and Potential Role of Clinical Pharmacology: A Workshop Summary. Clinical Pharmacology & Therapeutics 2023;113(1):37 View
  3. Sun Y, Hendrix A, Muluneh B, Ozawa S. Online Pharmacy Accessibility of Imatinib, An Oral Chemotherapy Medication. Journal of the National Comprehensive Cancer Network 2022;20(7):808 View
  4. Haji M, Kerbache L, Al-Ansari T. Evaluating the Performance of a Safe Insulin Supply Chain Using the AHP-TOPSIS Approach. Processes 2022;10(11):2203 View